Real Stories

  • "Before I took GLUCO-Z™, I was on 1000mg twice a day of Metformin. My sugar levels were 125-145 for the morning test and 190-210 for the night test.  After 2.5 weeks on GLUCO-Z™, my sugar levels ranged 107-115. And my night time was ranging between 150-180. After a month on GLUCO-Z™, I even had a score of 97! " Jerry Yu, Renton, WA
  • “.... A good friend told me about GLUCO-Z™. Reluctantly, having tried other products in the past that did nothing special, I decided to give the stuff a go. You would not think that something would work this quickly, but it has and am I thrilled....”Alan Braunstein, Seattle, WA
more real stories

About GLUCO-Z™

GLUCO-Z™ is a patented natural pharmaceutical grade compound that directly addresses and helps the root cause of blood sugar imbalance and insulin resistance that exists in every member of the diabetes and pre-diabetes communities – zinc mal-absorption syndrome. Our product is the first scientifically proven, non-pharmaceutical answer to helping people with diabetes manage their disease from within. GLUCO-Z™ is unique even among other treatments, including diabetes drugs, because it offers a powerful tool for blood sugar management and insulin resistance without the potentially serious side effects.

 

The subject of over 30 years of study, in human clinical studies conducted in 1998 under a National Institutes of Health (NIH) grant at the Veterans Affairs (VA) hospital in Los Angeles, California, GLUCO-Z™ was shown to balance blood sugar and insulin resistance for the subjects tested. Additional lengthier studies were conducted with equally excellent results between 2007 and 2008. 

 

 

GLUCO-Z™ Science

After insulin binds to its receptor on the surface of cell membrane and induction of signal transduction for glucose uptake, insulin bound insulin-receptors are transported into the endosome. Upon release of the insulin from its receptor, insulin is hydrolyzed and degraded by IDE. Incomplete digestion of insulin fragments may lead toward hyperinsulinemia and zinc deficiency causing insulin resistance and diabetes.

 

During the clinical trials held at the VA hospital in Los Angeles, the trial users suffered from a multitude of ailments. Many were of advanced age and were in poor health with poor diet and exercise patterns. Even so, all participants achieved significant improvements to blood sugar balances within two months. While under medical supervision, trial members were able to demonstrate overall improvements to systemic health.